The world-renowned cannabinoid researcher, Dr. Ethan Russo, joins us on Cannabis Legalization to discuss the science of cannabinoids, terpenoids, and all things cannabis. We’ve all benefited from Dr. Russo’s research on the endocannabinoid system and the entourage effect. Dr. Russo founded CReDO Science along with Nishi Whiteley to commercialize patented cannabis products generated from their research on cannabis and the endocannabinoid system.
“In Latin, CReDO means ‘I believe’. We maintain that “the proof is out there” for cannabis/hemp-based solutions for better living. Through our research we aim to understand how to apply components of the cannabis plant to balance the ECS as well as identify markers of ECS dysregulation for the treatment of disease. A unique business, CReDO Science is focused on the development of market disrupting technologies. To do that however, it is key to identify big solvable problems and conduct the preclinical and clinical research necessary to bring these products safely to market. Our goal is not only to bring the products to market for which we have initiated the patent process but also to innovate new solutions to big problems independently and collaboratively in the greatest areas of unmet need. Thus, we consider ourselves a ‘think-and-do-tank.’” – CReDO Science
